Masters CL - Search Results

1

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.

Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Bradfield NI, et al. Among authors: masters cl. Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):190-196. doi: 10.1097/WAD.0000000000000252. Alzheimer Dis Assoc Disord. 2018. PMID: 29561277

2

Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.

Fodero LR, Sáez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH. Fodero LR, et al. Among authors: masters cl. J Neurochem. 2002 May;81(3):441-8. doi: 10.1046/j.1471-4159.2002.00902.x. J Neurochem. 2002. PMID: 12065653 Free article.

3

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Laws SM, et al. Mol Psychiatry. 2002;7(8):886-90. doi: 10.1038/sj.mp.4001097. Mol Psychiatry. 2002. PMID: 12232782

4

Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype.

Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Thomas EA, et al. Biol Psychiatry. 2003 Jul 15;54(2):136-41. doi: 10.1016/s0006-3223(02)01976-5. Biol Psychiatry. 2003. PMID: 12873803

5

Spectrum of saccade system function in Alzheimer disease.

Shafiq-Antonacci R, Maruff P, Masters C, Currie J. Shafiq-Antonacci R, et al. Arch Neurol. 2003 Sep;60(9):1272-8. doi: 10.1001/archneur.60.9.1272. Arch Neurol. 2003. PMID: 12975294

6

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

Dean B, Laws SM, Hone E, Taddei K, Scarr E, Thomas EA, Harper C, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Dean B, et al. Biol Psychiatry. 2003 Sep 15;54(6):616-22. doi: 10.1016/s0006-3223(03)00075-1. Biol Psychiatry. 2003. PMID: 13129656

7

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL. Ritchie CW, et al. Among authors: masters cl. Arch Neurol. 2003 Dec;60(12):1685-91. doi: 10.1001/archneur.60.12.1685. Arch Neurol. 2003. PMID: 14676042 Clinical Trial.

8

Subtle memory decline over 12 months in mild cognitive impairment.

Maruff P, Collie A, Darby D, Weaver-Cargin J, Masters C, Currie J. Maruff P, et al. Dement Geriatr Cogn Disord. 2004;18(3-4):342-8. doi: 10.1159/000080229. Epub 2004 Aug 13. Dement Geriatr Cogn Disord. 2004. PMID: 15316183

9

Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.

Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, Barnham KJ, Strozyk D, Masters CL, Cherny RA, Bush AI. Opazo C, et al. Among authors: masters cl. Aging Cell. 2006 Feb;5(1):69-79. doi: 10.1111/j.1474-9726.2006.00196.x. Aging Cell. 2006. PMID: 16441845 Free article.

10

Mild memory impairment in healthy older adults is distinct from normal aging.

Weaver Cargin J, Maruff P, Collie A, Masters C. Weaver Cargin J, et al. Brain Cogn. 2006 Mar;60(2):146-55. doi: 10.1016/j.bandc.2005.10.004. Epub 2006 Jan 30. Brain Cogn. 2006. PMID: 16446021 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

988 results

Search Page